Skip to main content

Ian Davis, MD, PhD, is a UNC Lineberger Comprehensive Cancer Center member and G. Denman Hammond Professorship for Childhood Cancer at UNC-Chapel Hill. Davis is specifically involved with the Cancer Genetics, Pediatric Hematology-Oncology, and Cancer Epigenetics Training programs.

G. Denman Hammond Professor of Childhood Cancer
Associate Chief, Division of Pediatric Hematology-Oncology
Associate Director, Cancer Epigenetics Training Program
Co-leader, Cancer Genetics Program, UNC Lineberger Comprehensive Cancer Center
UNC-Chapel Hill
Cancer Genetics

Area of Interest

I am interested in the application of integrated genome-wide approaches to identify the epigenetic and chromatin biology consequences of genetic alterations in human cancers. Primary foci of the lab include Ewing sarcoma in which we explore the mechanism through which the necessary chromosomal translocation-derived fusion oncoprotein EWSR1-FLI1 regulates chromatin states and target genes. We also are evaluating the effect of mutations in the histone methyltransferase SETD2 and the chromatin remodeling complex member PBRM1 in clear cell renal cell carcinoma. Because of our expertise in epigenomics, we also collaborate with labs across the campus studying other cancers and developmental disorders.

Awards and Honors

  • Dick Vitale Pediatric Cancer Research Fund, The V Foundation, 2023
  • G. Denman Hammond Professorship for Childhood Cancer
  • Martin D. Abeloff V Scholar Award
  • Rita Allen Foundation Scholar

Find publications on PubMed

News and Stories

View all related posts

Caption available